Obstetrics and Gynecology

1046 questions

Question 981Question →

A 32-year-old woman, gravida 1, para 0, abortus 1, comes to the clinic to be evaluated for a 15-month history of inability to conceive. She reports that her menstrual cycles occur at regular 28-day intervals but consist of only very light spotting for 1 to 2 days. Prior to her pregnancy, her menses lasted 5 to 6 days with normal flow. Her obstetric history is significant for an elective termination of pregnancy 3 years ago at 9 weeks gestation. The procedure was complicated by heavy bleeding requiring a repeat dilation and curettage. She subsequently developed a fever and was successfully treated with intravenous antibiotics for postabortal endometritis. She takes a daily prenatal vitamin and has no other medical conditions. Her body mass index is 22 kg/m222 \text{ kg/m}^2. Pelvic examination reveals a normal-appearing cervix and a mobile, normal-sized uterus without adnexal masses.

Laboratory studies show:
Follicle-stimulating hormone: 6.2 mIU/mL6.2 \text{ mIU/mL}
Luteinizing hormone: 5.8 mIU/mL5.8 \text{ mIU/mL}
Estradiol: 90 pg/mL90 \text{ pg/mL}
Thyroid-stimulating hormone: 1.8 \muU/mL1.8 \text{ \mu U/mL}
Prolactin: 14 ng/mL14 \text{ ng/mL}

A 10-day course of oral medroxyprogesterone acetate is administered, but the patient experiences no vaginal bleeding upon cessation of the medication. Which of the following is the most likely pathophysiologic mechanism of this patient's current condition?

Show answer & explanation

Answer: Fibrous scarring and destruction of the endometrial stratum basalis

Answer

Fibrous scarring and destruction of the endometrial stratum basalis
The correct answer accurately describes the pathophysiology of Asherman syndrome (intrauterine adhesions). The endometrium consists of two layers: the stratum functionalis (which proliferates and sheds during the menstrual cycle) and the stratum basalis (the regenerative layer that serves as the source for the new functionalis). Severe trauma to the uterine cavity—most frequently from a dilation and curettage, particularly when accompanied by intrauterine infection (endometritis)—can permanently destroy the stratum basalis. Without this regenerative layer, the functionalis cannot develop, and the cavity becomes obliterated by fibrous bands (synechiae). Clinically, this manifests as secondary amenorrhea or profound hypomenorrhea and infertility. Because the hypothalamic-pituitary-ovarian axis remains completely intact, hormone levels (FSH, LH, estradiol) are normal. However, because the target tissue is unresponsive, patients will have a negative progestin withdrawal test despite having adequate circulating estrogen.

Step-by-Step Solution

1
Analyze the patient's clinical history and symptoms.
The patient has secondary infertility and severe hypomenorrhea following a complicated dilation and curettage with endometritis.
Intrauterine instrumentation complicated by infection is the classic major risk factor for Asherman syndrome.
2
Interpret the laboratory evaluation of the hypothalamic-pituitary-ovarian axis.
Follicle-stimulating hormone, luteinizing hormone, estradiol, thyroid-stimulating hormone, and prolactin levels are all entirely normal.
Normal hormone levels rule out primary ovarian insufficiency, functional hypothalamic amenorrhea, thyroid disorders, and hyperprolactinemia as causes for her inability to conceive.
3
Evaluate the clinical significance of the negative progestin challenge test.
The patient did not bleed after progestin withdrawal, despite having an adequate endogenous estradiol level (90 pg/mL90 \text{ pg/mL}).
A failure to bleed despite adequate estrogen priming confirms that the defect lies within the target tissue (endometrium) itself, confirming an anatomic outflow tract obstruction or unresponsiveness rather than anovulation.
4
Synthesize the findings to determine the exact pathophysiology.
The presentation is diagnostic of Asherman syndrome, caused by destruction of the stratum basalis.
Without the regenerative stratum basalis layer, the stratum functionalis cannot proliferate in response to circulating estrogen, leading to the formation of intrauterine adhesions (synechiae).

Key Concept

Asherman syndrome presents with secondary amenorrhea or hypomenorrhea and infertility due to fibrous scarring of the endometrial stratum basalis, typically following intrauterine instrumentation (like dilation and curettage) complicated by infection. Hormone levels are normal, but patients fail to bleed after a progestin challenge.
Question 982Question →

A 29-year-old nulligravid woman presents to the gynecology clinic for evaluation of an inability to conceive over the past 16 months. She reports that her menstrual cycles have become progressively infrequent, with her last menstrual period occurring 4 months ago. She also recently noticed a spontaneous, milky bilateral nipple discharge. Her past medical history is unremarkable, and she takes no medications. Vital signs are within normal limits. Pelvic examination is normal, and breast examination confirms bilateral galactorrhea. Arrange the following diagnostic and therapeutic steps in the most appropriate sequential order for the evaluation and management of this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence begins with ruling out pregnancy (urine beta-hCG), followed by biochemical evaluation (serum prolactin and TSH), anatomical imaging (MRI of the brain), first-line medical treatment (dopamine agonist therapy), and finally, surgical intervention only if medical management fails.
The evaluation of a patient with secondary amenorrhea and galactorrhea requires a strict algorithmic progression to avoid unnecessary testing and harm. Because pregnancy is the most common cause of these symptoms, a beta-hCG test is universally the first step. Once pregnancy is excluded, serum prolactin and TSH must be measured; TRH stimulates prolactin release, so primary hypothyroidism must be ruled out before assuming a pituitary origin. After confirming isolated hyperprolactinemia, a brain MRI is utilized to locate the adenoma. Treatment follows a unique paradigm in neuroendocrinology: prolactinomas are primarily managed medically with dopamine agonists, which shrink the tumor and restore fertility. Surgery is explicitly reserved as a last-line option for refractory cases.

Step-by-Step Solution

1
Rule out pregnancy
Excludes the most common physiologic cause of the patient's symptoms.
Before initiating any endocrine workup for secondary amenorrhea and galactorrhea, an ongoing pregnancy must be unequivocally ruled out using a beta-hCG test.
2
Assess prolactin and thyroid function
Confirms hyperprolactinemia and differentiates primary pituitary etiology from secondary causes like hypothyroidism.
Primary hypothyroidism leads to elevated TRH, which can act as a prolactin-releasing factor. Checking TSH prevents unnecessary brain imaging in patients who simply need levothyroxine.
3
Perform structural neuroimaging
Localizes the source of excess prolactin.
An MRI of the brain with sellar cuts is the gold standard to visualize microadenomas or macroadenomas once biochemical hyperprolactinemia is established.
4
Initiate medical therapy
Normalizes prolactin levels, restores ovulatory cycles, and shrinks the adenoma.
Dopamine agonists (cabergoline, bromocriptine) are uniquely effective for prolactinomas and serve as the definitive first-line therapy.
5
Consider surgical intervention
Physically removes the refractory or symptomatic adenoma.
Transsphenoidal surgery is strictly reserved for patients demonstrating resistance to dopamine agonists, experiencing intolerable side effects, or presenting with acute pituitary apoplexy.

Key Concept

Stepwise evaluation and management of secondary amenorrhea with galactorrhea (suspected prolactinoma).
Question 983Question →

A 27-year-old woman, G1P0, is evaluated in the obstetric triage area at 31 weeks gestation. She reports a sudden gush of clear vaginal fluid that occurred 48 hours ago. Since this morning, she has developed chills and diffuse abdominal discomfort. Her temperature is 39.2°C (102.6°F), blood pressure is 110/70 mmHg, and heart rate is 115/min. Physical examination reveals a tender uterine fundus. Speculum examination shows a pool of purulent fluid in the posterior vaginal fornix. Fetal monitoring demonstrates a baseline heart rate of 175/min with moderate variability and no decelerations. Tocodynamometry shows irregular uterine contractions occurring every 8 to 10 minutes. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Administration of broad-spectrum intravenous antibiotics and induction of labor

Answer

Administration of broad-spectrum intravenous antibiotics and induction of labor
The correct management for intra-amniotic infection (chorioamnionitis) is the administration of broad-spectrum intravenous antibiotics (e.g., ampicillin and gentamicin) and immediate delivery, typically via induction of labor. This patient has classic signs of infection: maternal fever, uterine tenderness, purulent fluid, and fetal tachycardia. In this setting, the risks of maternal sepsis and neonatal morbidity far outweigh the risks of prematurity at 31 weeks. Because the fetal heart rate tracing is reassuring (moderate variability, no decelerations), an induction of labor is safe and preferred over surgical delivery.

Step-by-Step Solution

1
Identify the primary diagnosis based on the clinical presentation.
The patient has preterm premature rupture of membranes (PPROM) complicated by intra-amniotic infection (chorioamnionitis), evidenced by maternal fever (39.2°C), fundal tenderness, purulent vaginal fluid, and fetal tachycardia.
Recognizing the transition from uncomplicated PPROM to an active intra-amniotic infection dictates a shift from conservative to active management.
2
Determine the definitive treatment requirement for the complication.
Intra-amniotic infection requires prompt delivery regardless of gestational age, alongside maternal broad-spectrum intravenous antibiotics to prevent maternal sepsis and treat fetal infection.
Continuing the pregnancy in the setting of an infected intrauterine environment drastically increases the risk of maternal and fetal mortality.
3
Select the optimal mode of delivery based on maternal and fetal status.
Vaginal delivery via induction of labor is preferred. Despite the fetal tachycardia (175/min), the presence of moderate variability and absence of decelerations indicates a reassuring fetal status.
Fetal tachycardia is a common, expected response to maternal fever. Without signs of acute hypoxic distress, there is no indication to expose the mother to the risks of an emergent cesarean delivery.

Key Concept

Intra-amniotic infection (chorioamnionitis) complicating preterm premature rupture of membranes (PPROM)
Question 984Question →

A married couple visits a fertility specialist to discuss their lack of success in having a second child. They have not used contraception for 1818 months. The 3232-year-old female partner states she has not menstruated since the birth of their son two years ago. She describes chronic lethargy, decreased appetite leading to a 44-kg (8.88.8-lb) weight loss, and frequently wearing sweaters even in warm weather. A review of her medical records reveals that her previous pregnancy ended in a vaginal delivery complicated by severe uterine atony and life-threatening blood loss, necessitating endotracheal intubation, massive transfusion, and emergency pelvic arterial embolization. She notes that she was never able to produce breast milk for her infant in the postpartum period. Physical examination reveals delayed relaxation of deep tendon reflexes and a blood pressure of 90/6090/60 mmHg. Which of the following pathophysiologic processes is most directly responsible for this patient's secondary amenorrhea and infertility?

Show answer & explanation

Answer: Infarction of the anterior pituitary gland

Answer

Infarction of the anterior pituitary gland
This patient's presentation is highly characteristic of Sheehan syndrome. During pregnancy, the anterior pituitary gland undergoes physiologic enlargement and becomes highly vascularized, making it exquisitely sensitive to drops in blood pressure. The profound hypovolemic shock resulting from her severe postpartum hemorrhage caused ischemic necrosis (infarction) of the anterior pituitary gland. This structural damage leads to panhypopituitarism. The destruction of lactotrophs causes a failure of lactation (agalactia). The loss of gonadotrophs (FSH/LH) results in secondary amenorrhea and infertility. The loss of thyrotrophs (TSH) causes secondary hypothyroidism, explaining her fatigue, cold intolerance, and delayed deep tendon reflexes. Finally, the loss of corticotrophs (ACTH) leads to secondary adrenal insufficiency, causing her weight loss and hypotension.

Step-by-Step Solution

1
Identify the key clinical syndrome based on the patient's history and current symptoms.
The patient experienced a life-threatening postpartum hemorrhage followed by multi-axis endocrine failure (agalactia, amenorrhea, fatigue, cold intolerance, weight loss, hypotension).
Recognizing the pattern of symptoms across multiple organ systems points toward a central regulatory failure rather than a single organ issue.
2
Correlate specific symptoms with their corresponding hormonal deficiencies.
Agalactia indicates prolactin deficiency. Amenorrhea and infertility indicate FSH/LH deficiency. Cold intolerance and delayed reflexes indicate TSH deficiency. Hypotension and weight loss indicate ACTH deficiency.
Mapping symptoms to hormones confirms panhypopituitarism.
3
Determine the pathophysiologic etiology linking the postpartum hemorrhage to panhypopituitarism.
Hypovolemic shock during delivery caused ischemic necrosis (infarction) of the physiologically enlarged anterior pituitary gland, leading to Sheehan syndrome.
The anterior pituitary is highly vascular and enlarges during pregnancy, making it exceptionally vulnerable to ischemia during severe hypovolemic events.

Key Concept

Sheehan syndrome (postpartum pituitary necrosis) presents with failure to lactate, amenorrhea, secondary hypothyroidism, and secondary adrenal insufficiency following a severe postpartum hemorrhage.
Estimated Time:1m 15s
Question 985Question →

A 3232-year-old woman is evaluated in the clinic for a 22-year history of inability to conceive. She has never been pregnant. She and her partner have been engaging in frequent, unprotected intercourse. Over the past 1818 months, her menstrual cycles have lengthened to 4545 to 6060 days, and she has noticed increased dark hair growth on her upper lip and chin, requiring her to shave twice a week. She also reports a 12-kg12\text{-kg} (26-lb26\text{-lb}) weight gain during this period, predominantly in her abdominal area, and says she feels profoundly weak when trying to climb the stairs to her apartment. She takes a daily multivitamin. Vital signs show a blood pressure of 154/96 mm Hg154/96 \text{ mm Hg}, pulse of 82/min82\text{/min}, and BMI of 33 kg/m233 \text{ kg/m}^2. Physical examination reveals a rounded, plethoric face and broad, violaceous stretch marks over the lower abdomen. Pelvic examination is unremarkable. Pelvic ultrasonography demonstrates bilaterally enlarged ovaries with multiple peripherally oriented small cysts. Which of the following is the most appropriate initial diagnostic step to ascertain the underlying cause of this patient's ovulatory dysfunction?

Show answer & explanation

Answer: 2424-hour measurement of urinary free cortisol

Answer

The correct answer is 2424-hour measurement of urinary free cortisol.
The correct answer is 2424-hour measurement of urinary free cortisol. This patient presents with a phenotype mimicking polycystic ovary syndrome (PCOS), including oligo-ovulation, hirsutism, and polycystic ovarian morphology. However, PCOS is a diagnosis of exclusion. This patient has prominent features of Cushing syndrome, including new-onset hypertension, central obesity, facial plethora, proximal muscle weakness (difficulty climbing stairs), and broad violaceous striae. The catabolic effects of excess cortisol on connective tissue and muscle differentiate Cushing syndrome from typical PCOS. Because hypercortisolism causes secondary insulin resistance and stimulates ovarian androgen production, it frequently mimics PCOS. The most appropriate initial step is to screen for hypercortisolism using one of three first-line tests: 2424-hour urinary free cortisol, late-night salivary cortisol, or an overnight low-dose dexamethasone suppression test.

Step-by-Step Solution

1
Identify the clinical syndrome presented by the patient.
The patient has signs of hyperandrogenism (hirsutism), oligo-ovulation (irregular menses), and polycystic ovaries on ultrasound, mimicking PCOS. However, she also has classic features of hypercortisolism (Cushing syndrome), including central obesity, a plethoric face, proximal muscle weakness, broad violaceous striae, and hypertension.
Polycystic ovary syndrome (PCOS) is a diagnosis of exclusion. Other endocrinopathies must be considered, especially when specific pathognomonic signs are present.
2
Determine the relationship between Cushing syndrome and the patient's reproductive symptoms.
Excess cortisol leads to insulin resistance and compensatory hyperinsulinemia, which stimulates ovarian androgen production and alters gonadotropin release, producing a PCOS-like phenotype.
Understanding that Cushing syndrome can secondarily cause polycystic ovarian morphology and anovulation is key to selecting the primary diagnostic test.
3
Select the most appropriate initial diagnostic step for the suspected underlying condition.
Initial screening for Cushing syndrome includes 2424-hour urinary free cortisol, late-night salivary cortisol, or an overnight low-dose dexamethasone suppression test.
Establishing the presence of hypercortisolism is required before proceeding to find the anatomic source of the disease.

Key Concept

Cushing syndrome can mimic polycystic ovary syndrome (PCOS) by causing hyperandrogenism, oligo-ovulation, and polycystic ovaries. The presence of catabolic signs such as proximal myopathy and wide violaceous striae, along with hypertension, should prompt immediate screening for hypercortisolism.
Estimated Time:2m 0s
Question 986Question →

A 31-year-old primigravida at 38 weeks gestation is admitted to the labor and delivery triage unit for evaluation of severe preeclampsia. While speaking with the physician, she suddenly loses consciousness and begins exhibiting generalized tonic-clonic movements. Her blood pressure was recorded as 174/112 mm Hg five minutes prior to this event. Arrange the following steps in the most appropriate sequential order for the acute management of this patient's condition.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence for managing an eclamptic seizure prioritizes basic life support (airway and positioning), followed by targeted seizure cessation/prophylaxis (magnesium sulfate), then severe blood pressure control (antihypertensives), and ultimately concludes with definitive management (delivery) once the mother is stable.
The correct algorithm for eclampsia begins with supportive maternal care (airway protection and left lateral positioning). This is immediately followed by medical management to stop and prevent seizures using magnesium sulfate. Once seizures are addressed, severe hypertension is controlled with agents like labetalol to prevent stroke. Delivery is the definitive cure but is only initiated after the mother has been medically stabilized.

Step-by-Step Solution

1
Initiate supportive care by protecting the airway and placing the patient in the left lateral decubitus position.
Minimizes aspiration risk and maximizes maternal cardiac output.
Maternal hypoxia and aspiration are the most immediate life-threatening risks during a generalized tonic-clonic seizure.
2
Administer intravenous magnesium sulfate.
Stops ongoing seizure activity and prevents subsequent convulsions.
Magnesium sulfate is superior to benzodiazepines or phenytoin for eclamptic seizure management.
3
Administer intravenous labetalol or hydralazine.
Lowers severe blood pressure into a safe range.
Sustained severe hypertension in eclampsia carries a high risk of intracranial hemorrhage.
4
Prepare for and proceed with delivery.
Resolves the underlying pathophysiology of preeclampsia/eclampsia.
Delivery is the definitive treatment, but attempting delivery in an unstable, seizing patient leads to poor surgical and neonatal outcomes.

Key Concept

The management of eclampsia strictly follows a sequence of maternal stabilization: ABCs (Airway/Positioning) first, followed by magnesium sulfate for seizure control, antihypertensives for severe blood pressure elevation, and finally, definitive delivery.
Estimated Time:1m 15s
Question 987Question →

A 25-year-old nulliparous woman at 40 weeks and 2 days gestation is admitted to the labor and delivery unit for induction of labor. An intravenous oxytocin infusion is initiated. Six hours later, the patient is reporting significant pain but is coping well with epidural anesthesia. Her temperature is 37.4°C (99.3°F), blood pressure is 118/76 mmHg, and pulse is 92/min. The cervix is 6 cm dilated, 90% effaced, and the fetal head is at 0 station. Review of the external tocodynamometer over the past 30 minutes shows 7 uterine contractions per 10-minute window, with each contraction lasting 60 to 80 seconds. The continuous fetal heart rate monitor demonstrates a baseline of 130/min, minimal variability, and visually apparent, gradual decreases in the fetal heart rate that nadir after the peak of the contractions and return to baseline after the contractions conclude. The patient's hemoglobin is 10.8 g/dL with a normal mean corpuscular volume. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Discontinue the intravenous oxytocin infusion

Answer

Discontinue the intravenous oxytocin infusion
The correct answer is to discontinue the intravenous oxytocin infusion. This patient is experiencing uterine tachysystole, defined as more than 5 contractions in a 10-minute window averaged over 30 minutes. Uterine contractions temporarily interrupt blood flow to the intervillous space. When contractions are too frequent, the placenta does not have adequate time to reoxygenate between contractions, leading to uteroplacental insufficiency. This is manifesting on the fetal monitor as late decelerations (gradual decreases in fetal heart rate that begin after the peak of the contraction) and minimal variability. The immediate next step in management is intrauterine resuscitation to improve fetal oxygenation. The most direct and effective initial action when a patient is receiving an induction agent is to discontinue the oxytocin.

Step-by-Step Solution

1
Analyze the maternal contraction pattern on the tocodynamometer.
The tracing shows 7 contractions per 10 minutes.
To identify uterine tachysystole, which is defined as more than 5 contractions in a 10-minute period averaged over 30 minutes.
2
Evaluate the fetal heart rate tracing.
The tracing shows minimal variability and gradual decreases that nadir after the peak of the contraction.
To identify late decelerations, which indicate uteroplacental insufficiency secondary to the tachysystole.
3
Determine the most appropriate initial intervention.
Discontinue the oxytocin infusion.
Intrauterine resuscitation should begin immediately by removing the offending uterotonic agent causing the hyperstimulation.

Key Concept

Uterine tachysystole with late decelerations requires immediate intrauterine resuscitation, starting with the discontinuation of uterotonic agents like oxytocin.
Estimated Time:1m 30s
Question 988Question →

A married couple visits a reproductive endocrinology specialist to discuss their inability to conceive over the past 1414 months. The female partner, who is 3030 years old, reports that her menstrual periods ceased entirely 88 months ago. Prior to this, her cycles occurred predictably every 2828 days. Recently, she has been troubled by disrupted sleep, sudden episodes of warmth over her chest, and dyspareunia. Her past medical history is unremarkable. Family history is significant for her sister's 66-year-old son, who was recently diagnosed with global developmental delay, autism spectrum disorder, and large protruding ears. The patient's body mass index is 22 kg/m222 \text{ kg/m}^2. Pelvic examination shows thin, pale vaginal mucosa. A urine pregnancy test is negative. Laboratory studies demonstrate a serum follicle-stimulating hormone (FSH) level of 72 mIU/mL72 \text{ mIU/mL} and a luteinizing hormone (LH) level of 45 mIU/mL45 \text{ mIU/mL}.

Which of the following pathophysiologic mechanisms best explains this patient's current condition?

Show answer & explanation

Answer: Premutation expansion of a CGG trinucleotide repeat sequence

Answer

The correct pathophysiologic mechanism is the premutation expansion of a CGG trinucleotide repeat sequence.
This patient presents with secondary amenorrhea, infertility, and symptoms of estrogen deficiency (vasomotor symptoms, dyspareunia, thin vaginal mucosa). Her markedly elevated follicle-stimulating hormone (FSH) and luteinizing hormone (LH) levels confirm a diagnosis of hypergonadotropic hypogonadism, which in a woman under age 40 defines primary ovarian insufficiency (POI). The critical clue to the underlying etiology is her family history of a nephew with developmental delay, autism, and large ears, which is the classic presentation of Fragile X syndrome. Fragile X syndrome is caused by a full mutation (>200 CGG repeats) in the FMR1 gene. Females who carry the premutation (55-200 CGG repeats) do not typically have intellectual disability but are at a roughly 20% risk of developing FMR1-related POI. The premutation leads to the toxic accumulation of FMR1 mRNA, causing accelerated apoptosis of ovarian follicles and the early cessation of menses.

Step-by-Step Solution

1
Identify the primary clinical syndrome based on the patient's symptoms and laboratory results.
The combination of secondary amenorrhea, vasomotor symptoms (hot flashes), vaginal atrophy, and markedly elevated FSH/LH indicates hypergonadotropic hypogonadism, specifically primary ovarian insufficiency (POI).
Elevated gonadotropins in the setting of clinical estrogen deficiency confirm that the defect lies at the level of the ovary (loss of negative feedback) rather than the hypothalamus or pituitary.
2
Analyze the provided family history to determine the specific etiology of the POI.
The nephew's classic triad of developmental delay, autism spectrum disorder, and large protruding ears is highly characteristic of Fragile X syndrome.
Connecting the patient's ovarian failure to her sister's child's genetic disorder isolates the exact molecular mechanism responsible for her infertility.
3
Correlate Fragile X genetics with female ovarian function.
The patient is likely a carrier of the FMR1 premutation (55-200 CGG trinucleotide repeats).
Female carriers of the FMR1 premutation have a 20% risk of developing POI due to accelerated follicular depletion, perfectly explaining her clinical presentation.

Key Concept

Primary Ovarian Insufficiency (POI) associated with the Fragile X (FMR1 gene) premutation.
Question 989Question →

A 30-year-old nulligravid woman comes to the clinic for infertility evaluation. She and her husband have been unable to conceive after 18 months of regular, unprotected intercourse. She has irregular menstrual cycles occurring every 45 to 90 days and was diagnosed with polycystic ovary syndrome (PCOS) three years ago. Her body mass index (BMI) is 34 kg/m². A recent hysterosalpingogram demonstrates bilateral tubal patency, and her husband's semen analysis is within normal limits. Arrange the following therapeutic interventions in the most appropriate stepwise order for managing this patient's infertility, from initial management to advanced treatments.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence for managing PCOS-related infertility in an obese patient begins with lifestyle modifications for weight loss, followed by ovulation induction with letrozole, then exogenous gonadotropins, and finally in vitro fertilization (IVF).
The standard protocol for anovulatory infertility in obese patients with PCOS follows a step-up approach to minimize risks while maximizing success. Weight loss (5-10%) via lifestyle modification is the foundational first step, as it can spontaneously restore ovulation. If unsuccessful, letrozole is the first-line oral ovulation induction agent. Patients refractory to letrozole progress to second-line therapies, such as exogenous gonadotropins or laparoscopic ovarian drilling. If all less invasive measures fail, in vitro fertilization (IVF) is the definitive third-line option.

Step-by-Step Solution

1
Identify the primary cause of infertility.
The patient has anovulatory infertility secondary to PCOS, exacerbated by obesity. Tubal and male factors have been ruled out.
Establishing the etiology dictates the treatment ladder.
2
Determine the optimal first-line, non-pharmacological intervention.
Lifestyle modifications targeting weight loss are recommended first.
Weight reduction improves insulin sensitivity, lowers androgen levels, and often restores spontaneous ovulation in obese patients with PCOS.
3
Select the first-line pharmacological therapy if non-pharmacological measures fail.
Letrozole is chosen as the primary medical intervention.
Current guidelines recommend letrozole over clomiphene citrate for ovulation induction in PCOS due to superior ovulation and live birth rates.
4
Identify second and third-line therapies for refractory cases.
Exogenous gonadotropins are used next, followed by IVF as a last resort.
This stepwise escalation balances the chance of conception with the risks of multiple gestation and ovarian hyperstimulation syndrome (OHSS), reserving the most invasive and costly treatments for refractory cases.

Key Concept

Stepwise Management of Infertility in Polycystic Ovary Syndrome (PCOS)
Estimated Time:1m 15s
Question 990Question →

A multiparous patient (G3P2) at 3939 weeks of gestation is evaluated in the labor unit. She is experiencing painful uterine contractions every 33 minutes. Her pregnancy has been uncomplicated. Her temperature is 37.1∘C37.1^\circ\text{C} (98.8∘F98.8^\circ\text{F}), blood pressure is 118/76 mmHg118/76\text{ mmHg}, and pulse is 82/min82\text{/min}. The baseline fetal heart rate is 140/min140\text{/min} with moderate variability and no decelerations. A cervical examination reveals 6 cm6\text{ cm} dilation, 80%80\% effacement, and the fetal vertex is at a −2-2 station. The physician performs an artificial rupture of membranes to augment labor. Immediately following the procedure, the continuous electronic fetal monitor reveals an abrupt decrease in the fetal heart rate to 70/min70\text{/min} that persists for 33 minutes. A repeat digital pelvic examination identifies a soft, compressible, pulsatile mass in the vaginal vault ahead of the fetal presenting part. Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Digitally elevate the fetal vertex and prepare the patient for an emergency abdominal delivery

Answer

The most appropriate next step is to digitally elevate the fetal vertex and prepare the patient for an emergency abdominal delivery (cesarean section).
The correct answer involves manually elevating the fetal presenting part to relieve pressure on the prolapsed umbilical cord, followed by an immediate abdominal delivery (cesarean section). This patient is presenting with an umbilical cord prolapse, a life-threatening obstetric emergency that typically occurs after the rupture of membranes when the fetal presenting part is unengaged (e.g., at a high station such as −2-2). The prolapsed cord becomes compressed between the fetal head and the maternal pelvis, leading to severe fetal hypoxia, which manifests as a sudden, prolonged fetal bradycardia. Immediate management requires relieving the compression by keeping a hand in the vagina to push the fetal head upward while concurrently mobilizing the surgical team for an emergency cesarean section.

Step-by-Step Solution

1
Identify the obstetric emergency based on the clinical presentation.
The patient has suffered an umbilical cord prolapse, characterized by a sudden, prolonged fetal bradycardia (70/min70\text{/min}) immediately following artificial rupture of membranes, along with a palpable, pulsatile vaginal mass.
Rupturing membranes when the fetal head is high (−2-2 station) allows the umbilical cord to slip past the presenting part, leading to mechanical compression.
2
Determine the immediate life-saving intervention for this condition.
The mechanical compression on the umbilical cord must be relieved manually by continuously elevating the fetal head.
Cord compression obstructs fetal blood flow, causing rapid and severe hypoxia. Relieving this physical pressure is the only way to temporarily restore fetal oxygenation.
3
Select the definitive mode of delivery.
An emergency abdominal delivery (cesarean section) is indicated.
Vaginal delivery is not imminent or safe given the high fetal station and the active cord prolapse, necessitating immediate surgical intervention.

Key Concept

Management of Umbilical Cord Prolapse
Question 991Question →

A 27-year-old woman comes to the office for evaluation of infertility. She and her husband have been trying to conceive for 14 months without success. Her last menstrual period was 7 months ago; prior to that, her menses occurred irregularly every 40 to 60 days. The patient reports a 4-kg (8.8-lb) weight gain over the past year, generalized fatigue, and occasional morning headaches. She notes mild worsening of facial acne. She takes no medications and has no other medical conditions. Her BMI is 24 kg/m224 \text{ kg/m}^2. Blood pressure is 110/70 mmHg110/70 \text{ mmHg} and pulse is 62/min62/\text{min}. Physical examination shows a few open comedones on her chin but no hirsutism, clitoromegaly, or galactorrhea. Pelvic examination is unremarkable.

Laboratory results are as follows:

Human chorionic gonadotropin: negative
Follicle-stimulating hormone: 2.2 mIU/mL2.2 \text{ mIU/mL}
Luteinizing hormone: 1.8 mIU/mL1.8 \text{ mIU/mL}
Prolactin: 18 ng/mL18 \text{ ng/mL}
Thyroid-stimulating hormone (TSH): 1.0 mIU/L1.0 \text{ mIU/L} (normal: 0.5–5.0)
Free thyroxine (T4): 0.5 ng/dL0.5 \text{ ng/dL} (normal: 0.9–1.7)
Total testosterone: 35 ng/dL35 \text{ ng/dL} (normal: 15–70)

Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Magnetic resonance imaging of the brain

Answer

Magnetic resonance imaging of the brain
This patient presents with infertility, secondary amenorrhea, weight gain, fatigue, and headaches. Her laboratory results demonstrate a low free T4 alongside an inappropriately normal TSH, which is the classic diagnostic pattern for central (secondary) hypothyroidism. Furthermore, her FSH and LH levels are low despite 7 months of amenorrhea, indicating concurrent hypogonadotropic hypogonadism. The presence of multiple anterior pituitary hormone deficiencies in combination with morning headaches is highly suspicious for a space-occupying structural lesion in the sellar or suprasellar region, such as a nonfunctioning pituitary macroadenoma or craniopharyngioma. The most appropriate next step in management is magnetic resonance imaging of the brain to evaluate the pituitary gland. It is critical to image the brain and evaluate for concomitant central adrenal insufficiency (via serum cortisol and ACTH testing) before initiating any thyroid hormone replacement. Administering levothyroxine to a patient with undiagnosed central adrenal insufficiency increases cortisol clearance and can precipitate an acute, life-threatening adrenal crisis.

Step-by-Step Solution

1
Interpret the thyroid function tests.
Low free T4 (0.5 ng/dL0.5 \text{ ng/dL}) with an inappropriately normal TSH (1.0 mIU/L1.0 \text{ mIU/L}).
This specific pattern identifies central (secondary) hypothyroidism rather than primary hypothyroidism.
2
Analyze the reproductive hormone panel.
Low FSH and LH in the setting of prolonged secondary amenorrhea.
This indicates concurrent hypogonadotropic hypogonadism, ruling out primary ovarian insufficiency.
3
Synthesize the clinical and laboratory findings.
Multiple anterior pituitary hormone deficiencies accompanied by new-onset morning headaches.
The combination strongly points to a structural lesion in the sellar or suprasellar region (e.g., nonfunctioning pituitary macroadenoma).
4
Determine the next best step in management.
Magnetic resonance imaging of the brain.
Imaging is required to visualize the pituitary gland and hypothalamus to formally diagnose the structural cause before any hormone replacement therapy is initiated.

Key Concept

Evaluation of infertility and secondary amenorrhea caused by hypopituitarism (central hypothyroidism and hypogonadotropic hypogonadism).
Question 992Question →

A 21-year-old university student is brought to the outpatient clinic by her older sister because she has not had a menstrual period in 8 months. She experienced menarche at 13 years of age and subsequently had regular 29-day cycles. Over the past year, she has been training intensively for a regional triathlon and adhering to a strict, calorie-restricted vegan diet. She reports feeling occasionally fatigued but denies headaches, visual disturbances, or hot flashes. She takes no medications and is not sexually active. Her temperature is 36.6°C (97.9°F), blood pressure is 96/60 mm Hg, and pulse is 48/min. Her BMI is 16.8 kg/m2. Physical examination shows a very thin woman with fine, soft hair over her arms and back. Pelvic examination is unremarkable, and a urine pregnancy test is negative. Which of the following serum hormone profiles is most likely to be found in this patient?

Show answer & explanation

Answer: Decreased follicle-stimulating hormone, decreased luteinizing hormone, decreased estradiol

Answer

Decreased follicle-stimulating hormone, decreased luteinizing hormone, decreased estradiol
The correct answer is decreased follicle-stimulating hormone (FSH), decreased luteinizing hormone (LH), and decreased estradiol. This patient's presentation of secondary amenorrhea, intense athletic training, calorie restriction, low BMI, bradycardia, and lanugo hair is classic for functional hypothalamic amenorrhea (FHA). FHA develops due to a relative energy deficit, leading the body to suppress the hypothalamic-pituitary-ovarian (HPO) axis to conserve energy. This suppression decreases the pulsatile secretion of gonadotropin-releasing hormone (GnRH) from the hypothalamus. As a result, the anterior pituitary is not adequately stimulated, leading to decreased levels of FSH and LH. Without gonadotropin stimulation, the ovaries do not produce normal amounts of estradiol, creating a state of hypogonadotropic hypogonadism. FHA is a key component of the female athlete triad, which includes low energy availability, menstrual dysfunction, and decreased bone mineral density.

Step-by-Step Solution

1
Identify the most likely cause of the patient's secondary amenorrhea based on history and physical examination.
The patient has Functional Hypothalamic Amenorrhea (FHA).
Her presentation of intense athletic training, strict calorie-restricted dieting, significant bradycardia, low BMI, and lanugo hair strongly suggests severe energy deficiency leading to reproductive suppression.
2
Determine the underlying pathophysiology of Functional Hypothalamic Amenorrhea.
FHA is characterized by the suppression of pulsatile Gonadotropin-Releasing Hormone (GnRH) release from the hypothalamus.
In states of negative energy balance, the body attempts to conserve energy by downregulating non-essential physiological processes, such as the reproductive axis.
3
Correlate the pathophysiology with the expected laboratory profile.
Decreased GnRH leads to decreased production of follicle-stimulating hormone (FSH) and luteinizing hormone (LH), which in turn leads to decreased estradiol.
The anterior pituitary requires pulsatile GnRH stimulation to release gonadotropins; without them, the ovaries are not stimulated to produce estrogen, resulting in hypogonadotropic hypogonadism.

Key Concept

Pathophysiology and laboratory findings in functional hypothalamic amenorrhea
Estimated Time:1m 0s
Question 993Question →

A 34-year-old G1P0 woman at 3737 weeks of gestation is currently hospitalized and receiving an intravenous magnesium sulfate infusion for the management of severe preeclampsia. During a routine clinical assessment, the nurse notes that the patient has become increasingly somnolent and difficult to arouse. Her vital signs show a blood pressure of 152/98 mmHg152/98\text{ mmHg}, a heart rate of 88 /min88\text{ /min}, a respiratory rate of 8 /min8\text{ /min}, and an oxygen saturation of 86%86\% on room air. Continuous fetal heart rate monitoring demonstrates a baseline of 130 /min130\text{ /min} with minimal variability and no decelerations. Neurological examination reveals bilaterally absent patellar reflexes. Urine output has been 40 mL40\text{ mL} over the last 44 hours. Arrange the following acute management steps in the most appropriate chronological sequence for this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence for managing acute magnesium toxicity is to first halt the magnesium infusion, followed by securing the airway and providing ventilatory support, then administering intravenous calcium gluconate, and finally obtaining serum laboratory studies.
The established resuscitation algorithm for severe magnesium toxicity prioritizes removing the source (stopping the infusion) and securing the patient's ABCs (airway, breathing, circulation) before administering specific pharmacological antidotes or obtaining diagnostic labs. Hypoxia from respiratory failure will cause irreversible harm if the airway is not secured prior to or simultaneously with drawing labs and giving calcium.

Step-by-Step Solution

1
Identify the clinical presentation of magnesium toxicity.
The patient exhibits profound somnolence, respiratory depression, absent reflexes, and oliguria.
Recognizing the signs of toxicity is required before initiating the specific treatment sequence.
2
Determine the first priority in toxicological emergencies.
Halt the continuous intravenous magnesium sulfate infusion.
Removing the offending agent is the most direct way to prevent further physiological deterioration.
3
Address acute life-threatening complications.
Apply supplemental oxygen and initiate positive pressure ventilation.
Respiratory failure is the most immediate cause of morbidity and mortality in severe hypermagnesemia; securing the ABCs is paramount.
4
Administer the specific pharmacological antidote.
Administer an intravenous dose of calcium gluconate.
Calcium acts as a direct antagonist to magnesium at the neuromuscular junction, reversing the blockade and restoring respiratory drive.
5
Perform diagnostic and monitoring evaluations.
Draw blood for serum magnesium levels and a basic metabolic panel.
Laboratory values confirm the diagnosis and assess renal clearance, but this diagnostic step should never delay active resuscitation.

Key Concept

The acute management of magnesium toxicity requires strict sequential prioritization: immediately stopping the infusion, ensuring airway and breathing stability, administering calcium gluconate, and finally obtaining subsequent laboratory studies.
Question 994Question →

An evaluation is requested for a 15-year-old adolescent who has not yet experienced menarche or any breast development. She is significantly shorter than her peers, with her height charting at the 2nd percentile for age. Examination demonstrates a broad chest with widely spaced nipples and a low posterior hairline. Pelvic examination reveals normal prepubertal female external genitalia. Arrange the following diagnostic and management steps in the most appropriate chronological order for this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: Measurement of serum FSH -> Karyotype analysis -> Transthoracic echocardiography -> Initiation of estrogen -> Addition of cyclic progestin.
The correct sequence logically follows the diagnostic and therapeutic principles for primary amenorrhea with absent breast development. Initial evaluation requires FSH testing to localize the defect to the ovaries. The clinical stigmata strongly suggest Turner syndrome, prompting karyotype analysis for definitive diagnosis. Once confirmed, screening for critical congenital anomalies with echocardiography is the standard of care before focusing on long-term endocrine management. Puberty induction relies on mimicking normal physiology: starting with low-dose estrogen to promote initial breast budding and bone growth, and intentionally delaying the addition of progestin for 1-2 years to prevent abnormal tubular breast formation while eventually securing endometrial protection.

Step-by-Step Solution

1
Determine the first laboratory evaluation based on the physical examination.
Measurement of serum FSH concentration is selected.
The patient has delayed puberty (absent breast development), pointing toward a defect in estrogen production. FSH differentiates central from peripheral causes.
2
Select the appropriate follow-up test for hypergonadotropic hypogonadism in a patient with dysmorphic features.
Peripheral blood karyotype analysis is ordered.
The clinical phenotype strongly suggests Turner syndrome, which must be confirmed genetically to guide further management.
3
Identify necessary baseline screening upon confirmation of the diagnosis.
Transthoracic echocardiography is performed.
Patients with Turner syndrome have a high risk of congenital heart defects that require immediate identification before focusing on endocrinologic therapy.
4
Establish the initial pharmacological step for puberty induction.
Unopposed low-dose transdermal estrogen is initiated.
Estrogen is required to promote initial breast budding, uterine growth, and bone mineral accretion.
5
Determine the timing for endometrial protection.
Cyclic progestin therapy is added.
Progestins are intentionally delayed for 1-2 years to optimize breast contour and avoid abnormal tubular breast development, after which they are necessary to prevent endometrial hyperplasia.

Key Concept

Diagnostic algorithm and sequential management of primary amenorrhea secondary to Turner syndrome.
Question 995Question →

Match each patient's clinical presentation and laboratory profile with the most likely underlying etiology of her infertility or amenorrhea.

Click a left item, then click its matching right item

Items

33-year-old woman with 6 months of amenorrhea, severe hot flashes, and vaginal atrophy; laboratories show elevated FSH and low estradiol.
22-year-old cross-country runner with amenorrhea, BMI 16.5 kg/m², and normal thyroid-stimulating hormone; laboratories show low FSH, low LH, and low estradiol.
29-year-old woman with irregular menses, severe acne, and increased facial hair; ultrasound shows bilateral enlarged ovaries with multiple peripheral cysts.
31-year-old woman with bilateral milky nipple discharge, persistent headaches, and amenorrhea; laboratories show elevated prolactin and low FSH.

Matches

Show answer & explanation

Answer

1 matches with Primary ovarian insufficiency, 2 matches with Functional hypothalamic amenorrhea, 3 matches with Polycystic ovary syndrome, 4 matches with Pituitary adenoma.
The pairings correctly utilize hypothalamic-pituitary-ovarian axis laboratory patterns. Elevated FSH with low estrogen signifies primary ovarian failure. Low FSH/LH with low estrogen in a low-BMI patient points to functional hypothalamic suppression. Elevated prolactin with mass-effect symptoms identifies a pituitary adenoma. Hyperandrogenism with irregular menses is the hallmark of PCOS.

Step-by-Step Solution

1
Analyze the gonadotropin levels (FSH and LH) to localize the defect in the hypothalamic-pituitary-ovarian axis.
Elevated FSH points to an primary defect in the ovaries, while low or normal FSH points to a central defect in the hypothalamus or pituitary.
Differentiating primary from secondary hypogonadism is the critical first step in evaluating amenorrhea.
2
Evaluate the clinical context and other hormone levels for patients with central defects.
Low BMI and heavy exercise suggest hypothalamic suppression, whereas galactorrhea and headaches suggest a pituitary mass producing prolactin.
Clinical features identify the specific etiology of hypogonadotropic hypogonadism.
3
Assess for signs of androgen excess.
Clinical evidence of acne and hirsutism paired with characteristic ultrasound findings confirms polycystic ovary syndrome.
PCOS is the leading cause of normogonadotropic anovulatory infertility and hyperandrogenism.

Key Concept

The diagnostic evaluation of secondary amenorrhea and infertility relies on the pattern of gonadotropins (FSH, LH) and specific clinical findings (BMI, hyperandrogenism, galactorrhea) to localize the defect to the hypothalamus, pituitary, or ovaries.
Question 996Question →

A 29-year-old woman, gravida 0, seeks medical advice for a 9-month history of secondary amenorrhea and infertility. During the past 4 months, she has also noted severe cystic acne, increased terminal hair growth on her face and chest, and a noticeable deepening of her voice. She has no history of medical conditions and takes no medications. Her blood pressure is 126/80 mm Hg, pulse is 76/min, and BMI is 24 kg/m2kg/m^2. Physical examination demonstrates temporal balding, pronounced facial hirsutism, and clitoromegaly. Pelvic examination is limited by patient guarding, and no distinct adnexal masses are palpated. A urine β\beta-hCG test is negative. Laboratory evaluation reveals the following:

Total testosterone: 195 ng/dLng/dL (normal: 15-70 ng/dLng/dL)
Dehydroepiandrosterone sulfate (DHEAS): 210 μg/dL\mu g/dL (normal: 35-430 μg/dL\mu g/dL)
Prolactin: 14 ng/mLng/mL (normal: 4-23 ng/mLng/mL)
Thyroid-stimulating hormone: 2.1 μU/mL\mu U/mL

Which of the following is the most appropriate next step in the evaluation of this patient?

Show answer & explanation

Answer: Pelvic ultrasonography

Answer

Pelvic ultrasonography
The correct answer is pelvic ultrasonography because the patient presents with rapid-onset virilization (clitoromegaly, temporal balding, deepening voice) and significantly elevated serum testosterone with normal DHEAS. This clinical and laboratory profile points directly to an ovarian androgen-secreting tumor (e.g., Sertoli-Leydig cell tumor). The ovaries predominantly secrete testosterone, whereas the adrenal glands secrete DHEAS. Therefore, an isolated elevation in testosterone requires visualization of the ovaries via pelvic ultrasound.

Step-by-Step Solution

1
Differentiate between simple hyperandrogenism and frank virilization based on the clinical presentation.
The patient exhibits clitoromegaly, temporal balding, and a deepening voice, which are signs of frank virilization rather than simple hyperandrogenism (which typically presents only with acne and hirsutism).
Frank virilization indicates a rapidly progressive, likely neoplastic source of androgens, whereas simple hyperandrogenism suggests a benign functional disorder like PCOS or NCAH.
2
Interpret the laboratory values to localize the source of the excess androgens.
The total testosterone is markedly elevated (> 150 ng/dL), while the DHEAS level is completely normal.
Testosterone is secreted by both the ovaries and the adrenal glands, but DHEAS is exclusively produced by the adrenal glands. A high testosterone with normal DHEAS localizes the pathology to the ovaries.
3
Select the appropriate initial imaging modality to investigate the localized pathology.
Pelvic ultrasonography is chosen to image the ovaries.
Pelvic ultrasound is the first-line, standard-of-care imaging test for visualizing the female reproductive tract and evaluating for ovarian neoplasms such as Sertoli-Leydig cell tumors.

Key Concept

Differentiation of androgen-secreting tumors using biochemical markers (Testosterone vs. DHEAS) to guide specific site imaging.
Estimated Time:1m 30s
Question 997Question →

A married couple presents to the reproductive endocrinology clinic seeking assistance with conception after actively trying for 16 months without success. The female partner, who is 32 years of age, states that her menstrual cycles were previously regular but have occurred only three times in the past year. During this period, she has developed significant, dark hair growth on her face, chest, and lower abdomen. She is particularly distressed because she recently noticed a distinct deepening of her voice and a receding hairline. Physical examination reveals a body mass index of 22 kg/m². Pelvic examination demonstrates marked clitoromegaly. A urine β-hCG test is negative. Which of the following is the most appropriate initial laboratory evaluation for this patient?

Show answer & explanation

Answer: Measurement of serum testosterone and dehydroepiandrosterone sulfate

Answer

Measurement of serum testosterone and dehydroepiandrosterone sulfate
The patient's presentation of rapid-onset voice deepening, temporal balding, and clitoromegaly indicates severe virilization. Unlike simple hirsutism (excess terminal body hair in a male pattern), virilization implies massively elevated androgen levels, which are highly suspicious for an androgen-secreting tumor. The initial evaluation must include serum testosterone (to screen for an ovarian tumor source, such as a Sertoli-Leydig cell tumor) and dehydroepiandrosterone sulfate (DHEAS, to screen for an adrenal source, such as an adrenal adenoma or carcinoma).

Step-by-Step Solution

1
Identify the core clinical presentation.
The patient has oligomenorrhea, infertility, and signs of severe virilization (voice deepening, temporal balding, clitoromegaly) developing rapidly over one year.
Establishing the severity and timeline of hyperandrogenism is crucial for the differential diagnosis.
2
Differentiate between simple hirsutism and true virilization.
The presence of clitoromegaly and voice changes confirms true virilization, which is a red flag.
Simple hirsutism suggests benign conditions like Polycystic Ovary Syndrome (PCOS), whereas true, rapid-onset virilization suggests an androgen-secreting tumor.
3
Determine the appropriate diagnostic workup for the suspected etiology.
To evaluate a suspected androgen-secreting tumor, the source (ovarian versus adrenal) must be determined.
Testosterone is primarily secreted by the ovaries, while dehydroepiandrosterone sulfate (DHEAS) is specifically secreted by the adrenal glands. Measuring both identifies the tumor's location.

Key Concept

Evaluation of Severe Hyperandrogenism and Virilization
Estimated Time:1m 15s
Question 998Question →

Match each patient's clinical presentation with the most likely corresponding serum laboratory profile. All patients present with secondary amenorrhea or oligomenorrhea.

Click a left item, then click its matching right item

Items

A 22-year-old collegiate cross-country runner with a BMI of 17.5 kg/m² presenting with 8 months of amenorrhea.
A 28-year-old woman with a BMI of 31 kg/m² presenting with unpredictable menses every 2-6 months and severe facial acne.
A 34-year-old woman presenting with a 1-year history of amenorrhea, vaginal dryness, and episodes of sudden flushing.
A 26-year-old woman presenting with 6 months of amenorrhea and bilateral galactorrhea. Her thyroid gland is not enlarged.
A 30-year-old woman presenting with 9 months of amenorrhea, significant weight gain, constipation, and delayed deep tendon reflexes.

Matches

Show answer & explanation

Answer

The athlete (pt1) matches FHA (lab1); the patient with acne (pt2) matches PCOS (lab2); the patient with hot flashes (pt3) matches POI (lab3); the patient with galactorrhea (pt4) matches Prolactinoma (lab4); and the patient with delayed reflexes (pt5) matches Primary Hypothyroidism (lab5).
Each clinical scenario maps directly to a distinct pathophysiologic disruption of the hypothalamic-pituitary-ovarian axis. FHA suppresses central GnRH. PCOS alters GnRH pulsatility, driving preferential LH production. POI involves end-organ failure, triggering massive gonadotropin release. A prolactinoma centrally suppresses GnRH via isolated prolactin elevation. Hypothyroidism suppresses GnRH through TRH-induced hyperprolactinemia with characteristically elevated TSH.

Step-by-Step Solution

1
Analyze the patient with low BMI and high exercise (pt1).
Diagnose Functional Hypothalamic Amenorrhea (FHA).
Stress and low energy availability suppress the hypothalamus, leading to hypogonadotropic hypogonadism (lab1).
2
Analyze the patient with obesity, oligomenorrhea, and hyperandrogenism (acne) (pt2).
Diagnose Polycystic Ovary Syndrome (PCOS).
PCOS is associated with a hyperandrogenic state, high LH levels, and normal-to-high estrogen without elevated prolactin or TSH (lab2).
3
Analyze the patient with vasomotor symptoms (flushing, vaginal dryness) under age 40 (pt3).
Diagnose Premature Ovarian Insufficiency (POI).
Ovarian failure removes negative feedback on the pituitary, leading to hypergonadotropic hypogonadism with high FSH and LH (lab3).
4
Analyze the patient with galactorrhea and a normal thyroid (pt4).
Diagnose Prolactinoma.
Excess prolactin from a pituitary adenoma suppresses GnRH, leading to low FSH/LH, while TSH remains normal (lab4).
5
Analyze the patient with systemic hypometabolic symptoms (weight gain, delayed reflexes) (pt5).
Diagnose Primary Hypothyroidism.
Low T4 causes high TRH. TRH stimulates both TSH and prolactin, which in turn suppresses GnRH and gonadotropins (lab5).

Key Concept

Differentiation of secondary amenorrhea based on the hypothalamic-pituitary-ovarian axis and associated laboratory profiles.
Estimated Time:2m 0s
Question 999Question →

A 34-year-old man and his 31-year-old female partner present to the reproductive endocrinology clinic for evaluation of infertility after 2 years of unsuccessful attempts to conceive. The female partner's evaluation, including ovulation assessment and hysterosalpingography, is completely normal. The male partner provides a semen sample, and the initial semen analysis demonstrates severe oligospermia with a sperm concentration of 3 million/mL (normal > 15 million/mL). He is otherwise healthy and has no history of cryptorchidism, genitourinary trauma, or sexually transmitted infections. Arrange the following subsequent steps in the most appropriate sequential order for the comprehensive evaluation and management of this male partner's severe oligospermia.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence for managing severe oligospermia is: 1) Repeat the semen analysis, 2) Perform an endocrine evaluation, 3) Obtain genetic testing, and 4) Proceed to IVF with ICSI.
The diagnostic ladder for severe male factor infertility follows a strict protocol to avoid unnecessary testing and provide accurate prognostic information. Due to the high biological variability of semen parameters, a single abnormal semen analysis must first be confirmed with a repeat test 4 to 6 weeks later. If severe oligospermia (< 5 million sperm/mL) is confirmed, the next step is an endocrine evaluation (FSH, morning testosterone) to check for hypogonadism. Following this, genetic testing (karyotype and Y-chromosome microdeletion) is mandatory to identify underlying genetic etiologies (like Klinefelter syndrome) that could affect offspring. Finally, once the workup is complete and the couple is properly counseled, they can proceed to the definitive treatment, which is in vitro fertilization with intracytoplasmic sperm injection (IVF-ICSI).

Step-by-Step Solution

1
Confirm the abnormality in the initial laboratory finding.
Obtain a second semen analysis in 4 to 6 weeks.
Semen parameters are highly variable. Clinical decisions should never be based on a single abnormal semen analysis.
2
Differentiate the underlying etiology of confirmed severe oligospermia.
Measure serum FSH and early morning total testosterone.
Endocrine testing identifies potentially reversible secondary causes (like hypogonadotropic hypogonadism) versus primary testicular failure.
3
Screen for inheritable and structural chromosomal abnormalities.
Perform a peripheral karyotype and Y-chromosome microdeletion testing.
Men with sperm concentrations < 5 million/mL require genetic testing before assisted reproduction to counsel them on the risk of passing genetic defects to offspring.
4
Select the most appropriate assisted reproductive technology.
Utilize IVF combined with ICSI.
Standard IVF or intrauterine insemination (IUI) is ineffective for severe oligospermia. ICSI overcomes natural fertilization barriers by directly injecting a sperm into the egg.

Key Concept

Stepwise evaluation and management of severe male factor infertility
Question 1000Question →

A 27-year-old woman comes to the clinic seeking evaluation for primary infertility. She and her male partner have been having regular, unprotected intercourse for 14 months without conception. The patient notes that her menstrual cycles have always been unpredictable, occurring roughly every 45 to 90 days. She also reports bothersome dark hair growth on her chin, upper lip, and chest, which she removes weekly. She has no history of sexually transmitted infections or pelvic pain. Her body mass index is 29 kg/m², and her blood pressure is 118/76 mmHg. Physical examination reveals terminal hairs in a male-pattern distribution and mild facial acne, but there is no deepening of the voice, temporal balding, or clitoromegaly. Striae and proximal muscle weakness are absent. Pelvic ultrasound shows bilaterally enlarged ovaries, each containing over 15 small peripheral cysts. Morning laboratory tests obtained on day 3 of a progestin-induced withdrawal bleed show the following:

Laboratory TestResultReference Range
Thyroid-stimulating hormone1.8 µU/mL0.5-5.0 µU/mL
Prolactin14 ng/mL< 20 ng/mL
Total testosterone60 ng/dL15-70 ng/dL
Dehydroepiandrosterone sulfate2.1 µg/mL0.6-3.3 µg/mL
17-hydroxyprogesterone1,150 ng/dL< 200 ng/dL

Which of the following is the most likely diagnosis?

Show answer & explanation

Answer: Non-classic congenital adrenal hyperplasia

Answer

The most likely diagnosis is non-classic congenital adrenal hyperplasia.
The correct diagnosis is non-classic congenital adrenal hyperplasia (NCCAH). This patient presents with a classic triad of oligo-ovulation, clinical hyperandrogenism (hirsutism, acne), and polycystic ovaries on ultrasound. While these findings fulfill the Rotterdam criteria for polycystic ovary syndrome (PCOS), PCOS remains a diagnosis of exclusion. Current guidelines mandate ruling out other potential causes of hyperandrogenism. This patient's markedly elevated early morning 17-hydroxyprogesterone level (1,150 ng/dL) is the critical distinguishing factor. In NCCAH, a partial deficiency of the 21-hydroxylase enzyme prevents the normal conversion of 17-hydroxyprogesterone to 11-deoxycortisol. The accumulated 17-hydroxyprogesterone is shunted into the androgen synthesis pathway, leading to excess testosterone and the resulting clinical signs. A basal morning level greater than 800-1,000 ng/dL is considered diagnostic for 21-hydroxylase deficiency, making this the correct diagnosis rather than PCOS.

Step-by-Step Solution

1
Evaluate the patient's clinical presentation and ultrasound findings.
The patient has oligomenorrhea, hirsutism, and polycystic ovaries on ultrasound.
This triad fulfills the Rotterdam criteria, but requires the exclusion of other hyperandrogenic disorders to make a final diagnosis.
2
Analyze the laboratory results to rule out mimicking endocrinopathies.
TSH and prolactin are normal, ruling out thyroid disease and hyperprolactinemia. 17-hydroxyprogesterone is markedly elevated at 1,150 ng/dL.
A basal morning 17-hydroxyprogesterone level above 200 ng/dL is suspicious, and a level above 800-1,000 ng/dL is diagnostic for 21-hydroxylase deficiency.
3
Synthesize findings to arrive at the final diagnosis.
The high 17-hydroxyprogesterone level confirms that the patient's hyperandrogenism is of adrenal origin rather than idiopathic ovarian origin.
The 21-hydroxylase enzyme deficiency causes precursor accumulation and shunting toward androgen synthesis, perfectly explaining her PCOS-like presentation.

Key Concept

Evaluation of hyperandrogenism and infertility requires measuring 17-hydroxyprogesterone to distinguish polycystic ovary syndrome (a diagnosis of exclusion) from non-classic congenital adrenal hyperplasia.
Estimated Time:1m 30s
PreviousPage 50 / 53Next
Obstetrics and Gynecology Practice Questions — USMLE Step 2 CK — Page 50 | Examkin